| 380 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| 697 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| 5637 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| 22RV1 |
prostate |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| 23132-87 |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| 639-V |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| 647-V |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| 769-P |
kidney |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| 786-0 |
kidney |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| 8505C |
thyroid |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| 8-MG-BA |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| A101D |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| A172 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| A204 |
soft tissue |
Myomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| A2058 |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| A253 |
salivary gland |
Mucoepidermoid neoplasms |
GSE36133/Sanger Cell Line Project |
| A2780 |
ovary |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| A375 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| A3-KAW |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| A427 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| A431 |
skin |
Squamous cell neoplasms |
Sanger Cell Line Project |
| A498 |
kidney |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| A4-Fuk |
haematopoietic and lymphoid tissue |
Lymphoid leukemia |
GSE36133/Sanger Cell Line Project |
| A549 |
lung |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| A673 |
bone |
Miscellaneous bone tumors |
GSE36133/Sanger Cell Line Project |
| A704 |
kidney |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ABC-1 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ACHN |
kidney |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| ACN |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| AGS |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ALL-PO |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| AM-38 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| AML-193 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| AN3-CA |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ARH-77 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
Sanger Cell Line Project |
| AsPC-1 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| ATN-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| B2-17 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| BALL-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| BB30-HNC |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| BB49-HNC |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| BB65-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| BC-1 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| BC-3 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| BCPAP |
thyroid |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| BE-13 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| Becker |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| BEN |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| BFTC-905 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| BFTC-909 |
kidney |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| BHT-101 |
thyroid |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| BHY |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| BL-41 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| BL-70 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| BOKU |
cervix |
Squamous cell neoplasms |
Sanger Cell Line Project |
| BONNA-12 |
haematopoietic and lymphoid tissue |
Other leukemias |
Sanger Cell Line Project |
| BPH-1 |
prostate |
Hyperplasia |
Sanger Cell Line Project |
| BT-20 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| BT-549 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| BV-173 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| BxPC-3 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| C2BBe1 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| C32 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| C-33-A |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| C3A |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| C-4-II |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| C8166 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| CA46 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| Ca9-22 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| CAKI-1 |
kidney |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| CAL-120 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-12T |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-148 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-27 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| CAL-33 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| CAL-39 |
vulva |
Squamous cell neoplasms |
Sanger Cell Line Project |
| CAL-51 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-54 |
kidney |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| CAL-62 |
thyroid |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-72 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| CAL-85-1 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| Calu-1 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| Calu-3 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| Calu-6 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAMA-1 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| Caov-3 |
ovary |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| Caov-4 |
ovary |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| CAPAN-1 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| CAPAN-2-DSMZ-C |
pancreas |
Adenocarcinoma |
Sanger Cell Line Project |
| CaR-1 |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| CAS-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| Ca-Ski |
cervix |
Squamous cell neoplasms |
Sanger Cell Line Project |
| CCF-STTG1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| CCRF-CEM |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
NCI60/Sanger Cell Line Project |
| CESS |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| CFPAC-1 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| CGTH-W-1 |
thyroid |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ChaGo-K-1 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CHL-1 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| CHP-126 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| CHP-134 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| CHP-212 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| CMK |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| CML-T1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| COLO-205 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| COLO-320-HSR |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| COLO-668 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| COLO-678 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| COLO-679 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| COLO-680N |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| COLO-684 |
endometrium |
Adenocarcinoma |
Sanger Cell Line Project |
| COLO-720E |
ovary |
Adenocarcinoma |
Sanger Cell Line Project |
| COLO-741 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| COLO-792 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| COLO-800 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| COLO-824 |
breast |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| COR-L105 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| COR-L23 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| COR-L279 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| COR-L51 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| COR-L88 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| COR-L96CAR |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| CP66-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| CP67-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| CPC-N |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CRO-AP2 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| CRO-AP5 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| CTB-1 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| CTV-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| CW-2 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| D-245MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-247MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-263MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-283MED |
central nervous system |
Miscellaneous bone tumors |
GSE36133/Sanger Cell Line Project |
| D-336MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-384MED |
central nervous system |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| D-392MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-397MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-423MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-458MED |
central nervous system |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| D-502MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-538MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-542MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-556MED |
central nervous system |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| D-566MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| Daoy |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| Daudi |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| DB |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| DBTRG-05MG |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| DEL |
haematopoietic and lymphoid tissue |
Lymphoid neoplasm |
GSE36133/Sanger Cell Line Project |
| Detroit562 |
upper aerodigestive tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DG-75 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| DJM-1 |
skin |
other |
Sanger Cell Line Project |
| DK-MG |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| DMS-114 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DMS-153 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DMS-273 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DMS-53 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DMS-79 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DOHH-2 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| DOK |
upper aerodigestive tract |
epithelial dysplasia |
Sanger Cell Line Project |
| DoTc2-4510 |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| DSH1 |
urinary tract |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| DU-145 |
prostate |
Epithelial neoplasms, NOS |
GSE36133/NCI60/Sanger Cell Line Project |
| DU-4475 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DV-90 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| EB2 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| EB3 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| ECC10 |
stomach |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| ECC12 |
stomach |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| ECC4 |
gastrointestinal tract (site indeterminate) |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| EC-GI-10 |
oesophagus |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| EFM-19 |
breast |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| EFO-21 |
ovary |
Cystic, mucinous and serous neoplasms |
GSE36133/Sanger Cell Line Project |
| EFO-27 |
ovary |
Cystic, mucinous and serous neoplasms |
GSE36133/Sanger Cell Line Project |
| EGI-1 |
biliary tract |
Adenocarcinoma |
Sanger Cell Line Project |
| EHEB |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| EKVX |
lung |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| EM-2 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| EOL-1 |
haematopoietic and lymphoid tissue |
Chronic myeloproliferative disorders |
GSE36133/Sanger Cell Line Project |
| EPLC-272H |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| ES1 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES3 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES5 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES6 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES7 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES8 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ESS-1 |
endometrium |
Complex mixed and stromal neoplasms |
GSE36133/Sanger Cell Line Project |
| ETK-1 |
biliary tract |
Adenocarcinoma |
Sanger Cell Line Project |
| EVSA-T |
breast |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| EW-1 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-11 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-12 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-13 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-16 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-18 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-22 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-24 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-3 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-7 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| FaDu |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| FTC-133 |
thyroid |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| G-361 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| G-401 |
kidney |
Complex mixed and stromal neoplasms |
GSE36133/Sanger Cell Line Project |
| GA-10-Clone-20 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| GA-10-Clone-4 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| GAK |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| GAMG |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| GCIY |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| GCT |
soft tissue |
Malignant fibrous histiocytoma and pleomorphic sarcoma |
GSE36133/Sanger Cell Line Project |
| GDM-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| GI-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| GI-ME-N |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| GMS-10 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| GOTO |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| GOTO-P3 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| GP2d |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| GP5d |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| GR-ST |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| GT3TKB |
stomach |
Adenocarcinoma |
Sanger Cell Line Project |
| H4 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| H9 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
Sanger Cell Line Project |
| HA7-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| HAL-01 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| HC-1 |
haematopoietic and lymphoid tissue |
Other leukemias |
Sanger Cell Line Project |
| HCC1143 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1187 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1395 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1419 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1599 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1806 |
breast |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1937 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1954 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC2157 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC2218 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC2998 |
large intestine |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| HCC38 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC70 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCE-4 |
oesophagus |
Squamous cell neoplasms |
Sanger Cell Line Project |
| HCE-T |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| HCT-116 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133/NCI60/Sanger Cell Line Project |
| HCT-15 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| HDLM-2 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| HD-MY-Z |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| HEC-1 |
endometrium |
Adenocarcinoma |
Sanger Cell Line Project |
| HEL |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| HeLaSF |
cervix |
Adenocarcinoma |
Sanger Cell Line Project |
| H-EMC-SS |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| HGC-27 |
stomach |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HH |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| HL-60 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/NCI60/Sanger Cell Line Project |
| HLE |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| HMV-II |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| HN |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| HO-1-N-1 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| HOP-62 |
lung |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| HOP-92 |
lung |
Epithelial neoplasms, NOS |
NCI60/Sanger Cell Line Project |
| HOS |
bone |
Osseous and chondromatous neoplasms |
GSE36133/Sanger Cell Line Project |
| HPAF-II |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HS578T |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| HSC-2 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| HSC-3 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| HSC-4 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| HT |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| HT-1080 |
soft tissue |
Fibromatous neoplasms |
GSE36133/Sanger Cell Line Project |
| HT-1197 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HT-1376 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| HT-144 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| HT-29 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| HT-3 |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| HT-55 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| HTC-C3 |
thyroid |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| HuCCT1 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HuH-28 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HuH-6-clone5 |
liver |
Adenocarcinoma |
Sanger Cell Line Project |
| HuH-7 |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| HuNS1 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| HuO-3N1 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| HuO9 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| HuP-T3 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HuP-T4 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HUTU-80 |
small intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| IA-LM |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| IGR-1 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| IGROV-1 |
ovary |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| IM-9 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
Sanger Cell Line Project |
| IMR-5 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| IPC-298 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| IST-MEL1 |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| IST-MES1 |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| IST-SL1 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| IST-SL2 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| ITO-II |
testis |
Germ cell neoplasms |
Sanger Cell Line Project |
| J82 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| JAR |
placenta |
Trophoblastic neoplasms |
Sanger Cell Line Project |
| JEG-3 |
placenta |
Trophoblastic neoplasms |
Sanger Cell Line Project |
| JiyoyeP-2003 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| J-RT3-T3-5 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| JVM-2 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| JVM-3 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| K5 |
thyroid |
Adenocarcinoma |
Sanger Cell Line Project |
| KALS-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| KARPAS-299 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| KARPAS-422 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| KARPAS-45 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| KASUMI-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| KATOIII |
stomach |
Cystic, mucinous and serous neoplasms |
GSE36133/Sanger Cell Line Project |
| KE-37 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| KGN |
ovary |
Specialized gonadal neoplasms |
Sanger Cell Line Project |
| KINGS-1 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| KLE |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| KM12 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| KM-H2 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| KMOE-2 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| KMS-12-BM |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| KMS-12-PE |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
Sanger Cell Line Project |
| KNS-42 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| KNS-62 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KNS-81-FD |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| KO52 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| KOSC-2 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| KP-4 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| KP-N-RT-BM-1 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| KP-N-SI9s |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| KP-N-YN |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| KP-N-YS |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| KS-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| KU-19-19 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| KURAMOCHI |
ovary |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| KY821 |
haematopoietic and lymphoid tissue |
Leukemias, NOS |
Sanger Cell Line Project |
| KYSE-140 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-150 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-180 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-270 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-410 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-450 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-510 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-520 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-70 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| L-363 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| L-428 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| L-540 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| LAMA-84 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| LAN-1 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| LAN-5 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| LAN-6 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| LB1047-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| LB2241-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| LB2518-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| LB373-MEL-D |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| LB647-SCLC |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LB771-HNC |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| LB831-BLC |
urinary tract |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LB996-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| LC-1F |
lung |
Squamous cell neoplasms |
Sanger Cell Line Project |
| LC4-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| LCLC-103H |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| LCLC-97TM1 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| LK-2 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| LN-405 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| LNCaP-Clone-FGC |
prostate |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LOUCY |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| LoVo |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LOXIMVI |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| LP-1 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| LS-1034 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LS-123 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LS-174T |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| LS-411N |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LS-513 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LU-134-A |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LU-135 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LU-139 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LU-65 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| LU-99A |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LXF-289 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| M059J |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| M14 |
skin |
Nevi and melanomas |
NCI60/Sanger Cell Line Project |
| MALME-3M |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| MC-1010 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| MCF7 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| MC-IXC |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| MDA-MB-134-VI |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| MDA-MB-157 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| MDA-MB-175-VII |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| MDA-MB-231 |
breast |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| MDA-MB-361 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| MDA-MB-415 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| MDA-MB-435 |
skin |
Nevi and melanomas |
NCI60/Sanger Cell Line Project |
| MDA-MB-453 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| MDA-MB-468 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| ME-180 |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| MEG-01 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| MEL-HO |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| MEL-JUSO |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| MES-SA |
soft tissue |
Soft tissue tumors and sarcomas, NOS |
Sanger Cell Line Project |
| MeWo |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| MFE-280 |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| MFE-296 |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| MFH-ino |
soft tissue |
Malignant fibrous histiocytoma and pleomorphic sarcoma |
Sanger Cell Line Project |
| MFM-223 |
breast |
Ductal, lobular and medullary neoplasms |
Sanger Cell Line Project |
| MG-63 |
bone |
Osseous and chondromatous neoplasms |
GSE36133/Sanger Cell Line Project |
| MHH-CALL-2 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| MHH-CALL-4 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| MHH-ES-1 |
bone |
Miscellaneous bone tumors |
GSE36133/Sanger Cell Line Project |
| MHH-NB-11 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| MHH-PREB-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| MIA-PaCa-2 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| MJ |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| MKN1 |
stomach |
Complex epithelial neoplasms |
GSE36133/Sanger Cell Line Project |
| MKN28 |
stomach |
Adenocarcinoma |
Sanger Cell Line Project |
| MKN45 |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| MKN7 |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ML-2 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| MMAC-SF |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| MN-60 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| MOG-G-CCM |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| MOG-G-UVW |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| MOLT-13 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| MOLT-16 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| MOLT-4 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/NCI60/Sanger Cell Line Project |
| MONO-MAC-6 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| MPP-89 |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| MRK-nu-1 |
breast |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| MS-1 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| MSTO-211H |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| MUTZ-1 |
haematopoietic and lymphoid tissue |
Myelodysplastic syndrome |
Sanger Cell Line Project |
| MZ2-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| MZ7-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| NALM-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| NALM-6 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| NB1 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| NB10 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB12 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB13 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB14 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB16 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB17 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB19 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB4 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| NB5 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB6 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB69 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB7 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NBsusSR |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NCCIT |
testis |
mixed |
Sanger Cell Line Project |
| NCI-ADR-RES |
ovary |
Cystic, mucinous and serous neoplasms |
NCI60/Sanger Cell Line Project |
| NCI-H1048 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1092 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1105 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1155 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1299 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1304 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H1355 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1395 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1436 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1437 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H146 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1522 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H1563 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H157 |
lung |
Squamous cell neoplasms |
Sanger Cell Line Project |
| NCI-H1573 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1618 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1650 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1651 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1666 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1693 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1703 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| NCI-H1755 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1770 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H1792 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1793 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1838 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1926 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H1930 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1975 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1993 |
lung |
Adenocarcinoma |
Sanger Cell Line Project |
| NCI-H2009 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H2029 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H2030 |
lung |
Adenocarcinoma |